Literature DB >> 6539470

Significance of idiopathic deep venous thrombosis.

N T O'Connor, S A Cederholm-Williams, E W Fletcher, M Allington, A A Sharp.   

Abstract

The risk of developing an overt malignancy after an isolated deep venous thrombosis (DVT) is poorly documented. We therefore reviewed a series of patients in whom a solitary idiopathic DVT had been proven by venography at least 12 months earlier. No patient had developed a malignancy at follow-up. However, decreased fibrinolytic activity was observed in five out of the six patients aged less than 45 years. Patients with an idiopathic DVT should not be subjected to an exhaustive search for malignancy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539470      PMCID: PMC2417837          DOI: 10.1136/pgmj.60.702.275

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  The biological significance of fibrinolysis.

Authors:  T ASTRUP
Journal:  Lancet       Date:  1956-09-15       Impact factor: 79.321

2.  Significance of idiopathic venous thrombosis and hidden cancer.

Authors:  W G ANLYAN; W W SHINGLETON; G D DELAUGHTER
Journal:  J Am Med Assoc       Date:  1956-07-07

Review 3.  Diagnosis of deep-vein thrombosis.

Authors:  N Browse
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

4.  "Fibrinolytic capacity" in healthy volunteers at different ages as studied by standardized venous occlusion of arms and legs.

Authors:  B R Robertson; M Pandolfi; I M Nilsson
Journal:  Acta Med Scand       Date:  1972-03

5.  The phlebographic pattern of acute leg thrombosis within a defined urban population.

Authors:  G Nylander; H Olivecrona
Journal:  Acta Chir Scand       Date:  1976

6.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.

Authors:  G H Sack; J Levin; W R Bell
Journal:  Medicine (Baltimore)       Date:  1977-01       Impact factor: 1.889

7.  Thrombophlebitis of the lower extremities and ABO blood type.

Authors:  H Jick; J Porter
Journal:  Arch Intern Med       Date:  1978-10
  7 in total
  5 in total

1.  Should we look further for cancer in a patient with venous thromboembolism?

Authors:  D E Arterburn; W S Richardson
Journal:  West J Med       Date:  2000-05

2.  Recurrent thromboembolism as a hallmark of Cushing's syndrome.

Authors:  A La Brocca; M Terzolo; A Pia; P Paccotti; P De Giuli; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 3.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study.

Authors:  J T Murchison; L Wylie; D L Stockton
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

Review 5.  Haemostasis in malignant disease.

Authors:  M J Auger; M J Mackie
Journal:  J R Coll Physicians Lond       Date:  1988-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.